A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease.
| Autor: | Laskowitz DT, Kolls BJ, Laskowitz, Daniel T, Kolls, Brad J |
|---|---|
| Zdroj: | Neurology; 6/15/2010, Vol. 74 Issue 24, p2026-2027, 2p |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|